skip to primary navigationskip to content

Reflection Therapeutics

Creating new therapies for neurodegeneration

Reflection Therapeutics is creating a first in class treatment for ALS, also known as motor neurone disease (MND) or Lou Gehrig's disease.  Our aim is to protect motor neurons from an overactive immune system, prolonging motor neuron function and delaying disease progression.



Company Information

Year Founded

  • 2018


  • Twitter username <hyperlink>